Crosstalk between long non-coding RNAs and p53 signaling pathway in colorectal cancer: A review study

Pathol Res Pract. 2023 Sep:249:154756. doi: 10.1016/j.prp.2023.154756. Epub 2023 Aug 10.

Abstract

Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide and the third leading cause of cancer-related fatalities. Long non-coding RNAs (lncRNAs) are key regulators of diverse physiological processes and are dysregulated in a wide range of pathophysiological circumstances such as CRC. Studies revealed that aberrant expressions of lncRNAs clearly modulate the expression level of p53 gene in CRC, thereby transactivating multiple downstream pathways. P53 is regarded as a crucial tumor suppressor gene which promotes cell-cycle arrest, DNA repair, senescence or apoptosis in response to cellular stresses. P53 is also mutated in CRC as well as various types of human malignancies. Therefore, lncRNAs interact with the p53 signaling pathway in numerus ways and significantly influence CRC-related processes. The current findings in the investigation of the crosstalk between lncRNAs and the P53 pathway in controlling CRC carcinogenesis, tumor progression, and therapeutic resistance are summarized in the this review. A deeper knowledge of CRC carcinogenesis may also have implications in CRC prevention and treatment through more research.

Keywords: CRC; Carcinogenesis; Long non-coding RNAs; P53; Therapeutic resistance; Tumor progression.

Publication types

  • Review

MeSH terms

  • Carcinogenesis
  • Colorectal Neoplasms* / genetics
  • Humans
  • RNA, Long Noncoding* / genetics
  • Signal Transduction
  • Tumor Suppressor Protein p53 / genetics

Substances

  • RNA, Long Noncoding
  • Tumor Suppressor Protein p53